Mesa Laboratories, Inc. carries a market capitalization of 708.10M, placing it among publicly traded companies globally. Its enterprise value stands at 671.86M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 708.10M |
| Enterprise Value | 671.86M |
Mesa Laboratories, Inc. currently has 5.60M shares outstanding.
| Shares Outstanding | 5.60M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Mesa Laboratories, Inc. trades at a trailing price-to-earnings ratio of 115.34. The price-to-sales ratio is 2.22, and the price-to-book ratio stands at 2.95.
| PE Ratio | 115.34 |
| PS Ratio | 2.22 |
| PB Ratio | 2.95 |
| P/TBV Ratio | -7.36 |
| P/FCF Ratio | 9.53 |
| P/OCF Ratio | 9.94 |
On an enterprise value basis, Mesa Laboratories, Inc. trades at an EV/EBITDA multiple of 14.79 and an EV/FCF ratio of 10.49. The EV/Sales ratio of 2.69 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.89 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.69 |
| EV / EBITDA | 14.79 |
| EV / EBIT | 29.89 |
| EV / FCF | 10.49 |
Mesa Laboratories, Inc. maintains a current ratio of 1.79, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 77.08, indicating elevated leverage, while an interest coverage ratio of 4.19 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.79 |
| Quick Ratio | 1.14 |
| Debt / Equity | 77.08 |
| Debt / EBITDA | 3.20 |
| Interest Coverage | 4.19 |
Mesa Laboratories, Inc. posts a return on equity of 2.66 and a return on invested capital of 3.17.
| Return on Equity (ROE) | 2.66 |
| Return on Assets (ROA) | 1.12 |
| Return on Invested Capital (ROIC) | 3.17 |
| Return on Capital Employed (ROCE) | 2.94 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.23 |
Over the trailing twelve months, Mesa Laboratories, Inc. has paid 4.56M in income taxes, reflecting an effective tax rate of 48.69.
| Income Tax | 4.56M |
| Effective Tax Rate | 48.69 |
Mesa Laboratories, Inc.'s stock has gained approximately 70.9769% over the past 52 weeks. The 50-day moving average sits at 111.97, while the 200-day moving average is 96.74.
| Beta (5Y) | N/A |
| 52-Week Price Change | 70.9769% |
| 50-Day Moving Average | 111.97 |
| 200-Day Moving Average | 96.74 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Mesa Laboratories, Inc. generated 249.73M in revenue and converted that into 4.80M in net income, yielding earnings per share of 0.86. EBITDA reached 45.44M, while operating income came in at 22.48M.
| Revenue | 249.73M |
| Gross Profit | 160.34M |
| Operating Income | 22.48M |
| Pretax Income | 9.36M |
| Net Income | 4.80M |
| EBITDA | 45.44M |
| EBIT | 22.48M |
| Earnings Per Share (EPS) | 0.86 |
Mesa Laboratories, Inc. holds 30.70M in cash and equivalents against 145.50M in total debt, resulting in a net debt position of 112.17M. Total book value stands at 188.76M, with working capital of 45.53M providing operational flexibility.
| Cash & Cash Equivalents | 30.70M |
| Total Debt | 145.50M |
| Net Debt | 112.17M |
| Equity (Book Value) | 188.76M |
| Book Value Per Share | 33.73 |
| Working Capital | 45.53M |
Mesa Laboratories, Inc. produced 55.67M in operating cash flow over the past twelve months. After subtracting -2.80M in capital expenditures, free cash flow totaled 52.87M - equivalent to 9.51 per share.
| Operating Cash Flow | 55.67M |
| Capital Expenditures | -2.80M |
| Free Cash Flow | 52.87M |
| FCF Per Share | 9.51 |
Mesa Laboratories, Inc. operates with a gross margin of 64.21, reflecting its pricing power and cost economics. The operating margin of 9.00 and net profit margin of 1.92 provide insight into operational efficiency.
| Gross Margin | 64.21 |
| Operating Margin | 9.00 |
| Pretax Margin | 3.75 |
| Profit Margin | 1.92 |
| EBITDA Margin | 18.19 |
The company's payout ratio of 73.63 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.64 |
| Dividend Yield | N/A |
| Payout Ratio | 73.63 |
| Shareholder Yield | 7.89 |
| FCF Yield | 10.49 |
Mesa Laboratories, Inc. posts an Altman Z-Score of 2.23, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.23 |